FDA Proposes to Indefinitely Delay Obama Administration Amendments to FDA Regulations on Intended Use

We welcome your interest in AGG. However, we cannot represent you nor can we treat unsolicited information as confidential until we know that doing so will not create a conflict of interest. Accordingly, please DO NOT send information about any matter unless you have a written engagement letter from us stating that we represent you as a client.